{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:50:56Z","timestamp":1750827056274,"version":"3.40.5"},"reference-count":71,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to characterize adverse drug reactions (ADRs) to hydroxychloroquine in the setting of COVID\u201019, occurring in Italy in the period March to May 2020. The analysis of the combination therapy with azithromycin or\/and lopinavir\/ritonavir as well as a comparison with ADRs reported throughout 2019 was performed. ADRs collected by the Italian National Network of Pharmacovigilance were analyzed for their incidence, seriousness, outcome, coadministered drugs, and Medical Dictionary for Regulatory Activities classification. A total of 306 reports were gathered for the quarter of 2020: 54% nonserious and 46% serious, and half of the latter required either the hospitalization or its prolongation. However, most of them were either completely recovered (26%) or in the process of recovery (45%), except for 9 fatal cases. Throughout 2019, 38 reports were collected, 53% nonserious and 47% serious, but no deaths had been reported. Diarrhea, prolonged QT interval, and hypertransaminasemia were the most frequently ADRs reported in 2020, significantly higher than 2019 and specific for COVID\u201019 subjects treated with hydroxychloroquine. The logistic regression analyses demonstrated that the likelihood of serious ADRs, QT prolongation, and diarrhea significantly increased with hydroxychloroquine dosage. Coadministration of lopinavir\/ritonavir and hydroxychloroquine showed a positive correlation with diarrhea and hypertransaminasemia and a negative relationship with the ADR seriousness. The combination therapy with azithromycin was another independent predictor of a serious ADR. Off\u2010label use of hydroxychloroquine for COVID\u201019, alone or in combination regimens, was associated with increased incidence and\/or seriousness of specific ADRs in patients with additional risk factors caused by the infection.<\/jats:p>","DOI":"10.1002\/jcph.2006","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T12:37:58Z","timestamp":1637498278000},"page":"646-655","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Off\u2010Label Use of Hydroxychloroquine in COVID\u201019: Analysis of Reports of Suspected Adverse Reactions From the Italian National Network of Pharmacovigilance"],"prefix":"10.1002","volume":"62","author":[{"given":"Elettra","family":"Fallani","sequence":"first","affiliation":[{"name":"Dipartimento di Scienze della Vita Universit\u00e0 di Siena  Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Cevenini","sequence":"additional","affiliation":[{"name":"Dipartimento di Economia e Management Universit\u00e0 di Trento  Trento Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Enea","family":"Lazzerini","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Chirurgia e Neuroscienze Universit\u00e0 di Siena  Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Verdini","sequence":"additional","affiliation":[{"name":"Dipartimento del Farmaco Azienda USL Toscana Sud Est  Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3831-8669","authenticated-orcid":false,"given":"Simona","family":"Saponara","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze della Vita Universit\u00e0 di Siena  Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0156-0"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa237"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106028"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-2-69"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104904"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105960"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1732-2"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101663"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.06.099"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2020.08.019"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101791"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101738"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019014"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22240"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1849"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1844"},{"issue":"1","key":"e_1_2_10_22_1","first-page":"114","article-title":"Outcomes of hydroxychloroquine usage in united states veterans hospitalized with COVID\u201019","volume":"1","author":"Magagnoli J","year":"2020","journal-title":"Med (N Y)"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8630"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012410"},{"key":"e_1_2_10_25_1","article-title":"RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID\u201019: a multinational registry analysis","author":"Mehra MR","year":"2020","journal-title":"Lancet"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31324-6"},{"key":"e_1_2_10_27_1","article-title":"Effect of hydroxychloroquine in hospitalized patients with covid\u201019","author":"RECOVERY Collaborative Group","year":"2020","journal-title":"N Engl J Med"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202005-478SD"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2023184"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.03.024"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.016"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1787"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1834"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008662"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008937"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0888-2"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.05.014"},{"key":"e_1_2_10_38_1","unstructured":"WoosleyRL HeiseCW GalloT et\u00a0al.QTdrugs list.https:\/\/www.crediblemeds.org\/. Accessed October 31 2021."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.031"},{"issue":"1","key":"e_1_2_10_40_1","first-page":"7","volume":"142","author":"Lazzerini PE","year":"2020","journal-title":"COVID\u201019, arrhythmic risk, and inflammation: mind the gap! Circulation"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008920"},{"key":"e_1_2_10_42_1","unstructured":"European Medicines Agency.COVID\u201019: reminder of the risks of chloroquine and hydroxychloroquine.https:\/\/www.ema.europa.eu\/. Accessed October 30 2021."},{"key":"e_1_2_10_43_1","unstructured":"Italian Medicines Agency.COVID\u201019: AIFA limits the use of remdesivir in selected cases and allows for hydroxychloroquine to be used only in randomised clinical trials in an outpatient setting.https:\/\/www.aifa.gov.it\/. Accessed October 30 2021."},{"key":"e_1_2_10_44_1","unstructured":"Maintenance and Support Services Organization.Medical Dictionary for Regulatory Activity.https:\/\/www.meddra.org\/. Accessed October 20 2021."},{"key":"e_1_2_10_45_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.ATC classification index with DDDs 2021.https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed August 14 2021."},{"key":"e_1_2_10_46_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781118548387","volume-title":"Applied Logistic Regression","author":"Hosmer D","year":"2013"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.010"},{"key":"e_1_2_10_48_1","unstructured":"Liverpool Drug Interactions Group.Interaction checker.https:\/\/www.covid19\u2010druginteractions.org\/. Accessed October 30 2021."},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-01000-8"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-02920-1"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19741-6"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.012"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1830058"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199902)42:2<357::AID-ANR19>3.0.CO;2-J"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10307"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2020.06.019"},{"key":"e_1_2_10_57_1","unstructured":"Food and Drug Administration.Plaquenil (hydroxychloroquine sulfate) tablet. Full prescribing information.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/009768s053lbl.pdf. Accessed October 31 2020."},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.621676"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30276-9"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2020.11.012"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.09.038"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200528"},{"issue":"22","key":"e_1_2_10_63_1","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini PE","year":"2017","journal-title":"Eur Heart J"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0098-z"},{"key":"e_1_2_10_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6842"},{"key":"e_1_2_10_66_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208321"},{"key":"e_1_2_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.001"},{"key":"e_1_2_10_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31487"},{"key":"e_1_2_10_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.12.1374"},{"key":"e_1_2_10_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26407"},{"key":"e_1_2_10_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01809-y"},{"first-page":"1","volume-title":"Council for International Organizations of Medical Sciences. Practical Aspects of Signal Detection in Pharmacovigilance","year":"2010","key":"e_1_2_10_72_1"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.2006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcph.2006","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.2006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T17:13:25Z","timestamp":1692983605000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1002\/jcph.2006"],"URL":"https:\/\/doi.org\/10.1002\/jcph.2006","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"type":"print","value":"0091-2700"},{"type":"electronic","value":"1552-4604"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"2021-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}